CRO makes 5-year EDC tech-transfer deal

ASG's Ockham Development Group can now offer its sponsor customers EDC capabilities from etrials Worldwide, following the signing of a five-year in-licensing agreement. The deal is part of etrials' CRO partnership solutions program.

According to an announcement, the agreement equips Ockham to provide its customers automated capabilities for aggregating, monitoring and analyzing data, as well as developing studies. Ockham becomes self-sufficient in terms of conducting studies using etrials' EDC solutions, with etrials providing best practices, training, hosting, development, technical, and sales and marketing support.

The deal follows on the heels of etrials receipt of a NASDAQ notice letter citing the company for falling below the $10 million minimum in stockholder equity. Etrials has until June 2 to provide a plan to regain compliance with the requirement. The company said in an announcement that it expects to meet the deadline.

- read the EDC deal announcement
- read the NASDAQ notice release

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.